Back

Diurnal dynamics and psychobiological regulation of cell-free mitochondrial and nuclear DNA in human saliva

Behnke, A.; Shire, D.; Leonard, S.; Park, A.; Petri, L.; Goyal, A.; Kirschbaum, C.; Picard, M.; Trumpff, C.

2025-10-15 psychiatry and clinical psychology
10.1101/2025.10.13.25337887
Show abstract

Cell-free mitochondrial DNA (cf-mtDNA) has emerged as a dynamic molecular signal responsive to psychological stress and a potential biomarker of stress-related physiological adaptations. While previous work has established the acute stress reactivity of cf-mtDNA in saliva, little is known about its diurnal regulation. In this intensive-sampling study, we characterized the diurnal dynamics of saliva cf-mtDNA across one weekday and one weekend day in healthy adults (N = 25, 52% female, 826 samples). Saliva was collected at awakening, during the first hour post-awakening, and at hourly intervals throughout the day. Using a quantitative PCR-based assay, we observed a robust cf-mtDNA awakening response, with concentrations peaking approximately 45 minutes after waking (2.5-fold change, Cohens d = 0.90), followed by a second peak at 180 minutes post-awakening (5.7-fold change, d = 1.70) and relatively stable levels thereafter. Saliva cf-mtDNA closely tracked cell-free nuclear DNA (cf-nDNA) across time points (rS = .85), suggesting shared release mechanisms. Diurnal cf-mtDNA showed limited correspondence with cortisol and other hormones in saliva. Psychosocial stress indicators--including daily hassles, lack of social support, negative emotional affect, trait anxiety, fatigue, and depressive symptoms--were associated with higher awakening cf-mtDNA levels, a diminished awakening response, and lower diurnal variability. These findings suggest that saliva cf-mtDNA exhibits a diurnal rhythm and is sensitive to psychosocial stress exposure. By establishing its diurnal patterns and individual-level variability, this study advances saliva cf-mtDNA as a promising non-invasive biomarker to dynamically capture stress-related mitochondrial signaling.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Scientific Reports
based on 701 papers
Top 4%
15.8%
2
Translational Psychiatry
based on 94 papers
Top 1%
11.5%
3
PLOS ONE
based on 1737 papers
Top 53%
8.5%
4
Psychoneuroendocrinology
based on 12 papers
Top 0.1%
7.8%
5
Nature Communications
based on 483 papers
Top 12%
6.6%
50% of probability mass above
6
Brain, Behavior, and Immunity
based on 35 papers
Top 0.4%
5.2%
7
Proceedings of the National Academy of Sciences
based on 100 papers
Top 2%
4.6%
8
Molecular Psychiatry
based on 84 papers
Top 2%
2.9%
9
Addiction Biology
based on 13 papers
Top 0.7%
2.4%
10
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
based on 27 papers
Top 2%
1.6%
11
eLife
based on 262 papers
Top 21%
1.4%
12
Neuropsychopharmacology
based on 29 papers
Top 2%
1.4%
13
Biological Psychiatry
based on 36 papers
Top 4%
1.4%
14
Nature Medicine
based on 88 papers
Top 12%
1.3%
15
Communications Biology
based on 36 papers
Top 4%
0.8%
16
Science Advances
based on 52 papers
Top 5%
0.8%
17
Neuroscience & Biobehavioral Reviews
based on 19 papers
Top 3%
0.8%
18
Cells
based on 14 papers
Top 1%
0.8%
19
Clinical Epigenetics
based on 21 papers
Top 2%
0.8%
20
European Neuropsychopharmacology
based on 11 papers
Top 2%
0.8%
21
Frontiers in Neurology
based on 74 papers
Top 12%
0.7%
22
Brain, Behavior, & Immunity - Health
based on 11 papers
Top 0.9%
0.7%
23
eBioMedicine
based on 82 papers
Top 8%
0.7%
24
Frontiers in Genetics
based on 32 papers
Top 6%
0.7%
25
Biological Psychiatry Global Open Science
based on 23 papers
Top 3%
0.7%
26
Aging Cell
based on 21 papers
Top 2%
0.7%
27
Psychological Medicine
based on 52 papers
Top 7%
0.7%
28
Psychiatry Research
based on 33 papers
Top 5%
0.7%